Come up with a name for your new list and we'll add to it:
Embera NeuroTherapeutics raised a round of funding on October 12, 2010. Investors include
National Institute on Drug Abuse.
Embera NeuroTherapeutics is a development-stage pharmaceutical company focused on treating a broad range of addictions where the major clinical challenge is a limited range of effective therapies. Emb…